Market Overview

Lovenox: 2018 Drug Insights - Product Details on the Basis of MOA, Target, Dosage, Route of Administration, Molecule Type, Strength, Chemical Type and ATC Classification - ResearchAndMarkets.com

Share:

The "Lovenox
- Drug Insight, 2018"
drug pipelines has been added to ResearchAndMarkets.com's
offering.

'Lovenox Drug Insight, 2018' highlights the drug marketed details and
the Global API Manufacturers details across the globe along with the
location. The report covers the Global Market Assessment of the Lovenox
covering the historical global sales and also provides the Lovenox sales
estimation during the forecasted period (2018-2020).

The report also covers the patents information and market exclusivity
data, route of synthesis, market competition, and API manufacturers by
country. In addition to this, the report also provides the SWOT analysis
for Lovenox and emerging therapies in this space.

Scope

  • A review of the Lovenox, based on information derived from company and
    industry-specific sources
  • Product details on the basis of MOA, target, dosage, route of
    administration, molecule type, strength, Chemical type and ATC
    Classification
  • Coverage of the Drug Master Files and API Manufacturers by country
  • Patent Expiry Timeline and Exclusivity Details
  • Route of Synthesis of the API
  • Forecasted Sales Figure from 2018-2020
  • Market competition and emerging therapies
  • SWOT Analysis

Key Topics Covered

1. Introduction

2. Lovenox- Overview

  • Product Description
  • Route of Synthesis
  • Mechanism of Action
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Adverse Reactions
  • Regulatory Milestones by Region
  • Deals and Partnerships

3. Product Details

4. Lovenox Sales Assessment

  • Historical Sales
  • Forecasted Sales

5. Patent Details

6. Global API Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

7. Market Competition

8. Emerging Therapies

8.1 Drug 1: Company 1

  • Product Description
  • Research and Development
  • Product Development Activities

9. SWOT Analysis

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/pfcclh/lovenox_2018?w=4

View Comments and Join the Discussion!